软胶囊市场－全球产业规模、份额、趋势、机会和预测，按类型、应用、最终用途、地区和竞争格局划分，2020-2030年预测

2024年全球软胶囊市场规模为80.2亿美元，预计2030年将以7.86%的复合年增长率成长至126.3亿美元。软胶囊是一种特殊的口服剂型，其内部填充液体或半液体，外层包裹着柔软的胶状外壳，通常由动物明胶或植物基聚合物製成。市场成长的主要驱动因素包括：软胶囊製剂本身所具有的优势，例如更高的生物利用度和更易吞嚥；膳食补充剂和营养保健品的需求不断增长；以及慢性疾病盛行率的上升，使得有效给药的需求日益迫切。这些优势有助于提高患者依从性，并拓展软胶囊在製药、营养保健品和化妆品等领域的应用。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球软胶囊市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按类型（明胶基/动物基，非动物基）
  • 依用途分类（抗酸剂和抗胀气製剂、抗贫血製剂、抗发炎药、抗生素和抗菌药、止咳感冒製剂、保健品、维生素和膳食补充剂、怀孕用药、其他）
  • 依最终用途划分（製药公司、营养保健品公司、化妆品公司、合约生产组织）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美软胶囊市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲软胶囊市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区软胶囊市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲软胶囊市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲软胶囊市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球软胶囊市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Fuji Capsule Co Ltd
• Sirio Pharma Co Ltd
• Captek Softgel International Inc
• Thermo Fisher Scientific Inc
• EyePoint Pharmaceuticals Inc
• Catalent Inc
• EuroCaps Ltd
• Aenova Group GmbH
• Lonza Group AG
• Soft Gel Technologies Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Softgel Capsules Market, valued at USD 8.02 Billion in 2024, is projected to experience a CAGR of 7.86% to reach USD 12.63 Billion by 2030. Softgel capsules represent a specialized oral dosage form, comprising a liquid or semi-liquid fill enclosed within a soft, gelatinous shell typically composed of animal gelatin or plant-based polymers. The market's growth is primarily driven by several distinct factors, including the inherent benefits of softgel formulations such as improved bioavailability and ease of swallowing, increased demand for dietary supplements and nutraceuticals, and the rising prevalence of chronic diseases necessitating effective drug delivery. These attributes facilitate enhanced patient compliance and expand application across pharmaceutical, nutraceutical, and cosmetic sectors.

Key Market Drivers

The global softgel capsules market expansion is significantly propelled by the growing demand for dietary supplements and nutraceuticals, alongside rising consumer health awareness and a proactive approach to preventive healthcare. The burgeoning nutraceutical sector, which frequently utilizes softgel formulations for their effective delivery of active ingredients, remains a primary catalyst. According to the IADSA, at the start of 2023, the worldwide market for supplements was larger than USD 170 billion, underscoring the substantial base driving softgel production in this segment. This robust demand is further amplified by a global shift towards preventative health measures and increased consumer understanding of nutrition's role in well-being. This trend encourages a consistent uptake of supplements, for which softgels offer an appealing and convenient dosage form.

Key Market Challenges

A significant challenge impeding the expansion of the global softgel capsules market is the high production costs associated with specialized encapsulation machinery, stringent manufacturing controls, and the rising prices of raw materials. These economic factors directly influence the operational profitability and growth strategies of manufacturers within the sector. The substantial investment required for advanced encapsulation technologies, alongside the ongoing expenses of maintaining rigorous quality and regulatory compliance, significantly elevates overall manufacturing overheads.

Key Market Trends

The growing consumer preference for vegan and vegetarian products, coupled with increasing health and ethical considerations, is significantly driving the adoption of plant-based encapsulation materials in the softgel capsules market. This trend involves a shift from traditional animal-derived gelatin to alternatives such as pullulan, starch, and hydroxypropyl methylcellulose, which cater to a broader demographic seeking ethical and sustainable options. The move towards plant-based ingredients is evident in manufacturing capacity, with the Pharmaceutical Research and Manufacturers of America (PhRMA) reporting that Catalent alone accounted for nearly 14% of global plant-based capsule manufacturing capacity in 2023. This expansion underscores the market's response to evolving dietary preferences and clean label demands. In a notable development, IFF introduced new pectin-based technology in April 2023 to expand its vegan softgel offerings, reflecting industry innovation in sustainable solutions.

Key Market Players

• Fuji Capsule Co Ltd
• Sirio Pharma Co Ltd
• Captek Softgel International Inc
• Thermo Fisher Scientific Inc
• EyePoint Pharmaceuticals Inc
• Catalent Inc
• EuroCaps Ltd
• Aenova Group GmbH
• Lonza Group AG
• Soft Gel Technologies Inc.

Report Scope:

In this report, the Global Softgel Capsules Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Softgel Capsules Market, By Type:

• Gelatin-Based/Animal-Based
• Non-Animal-Based

Softgel Capsules Market, By Application:

• Antacid and Anti-Flatulent Preparation
• Anti-Anemic Preparations
• Anti-Inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplement
• Vitamin and Dietary Supplement
• Pregnancy
• Others

Softgel Capsules Market, By End Use:

• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Contract Manufacturing Organization

Softgel Capsules Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Softgel Capsules Market.

Available Customizations:

Global Softgel Capsules Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Softgel Capsules Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Gelatin-Based/Animal-Based, Non-Animal-Based)
  • 5.2.2. By Application (Antacid and Anti-Flatulent Preparation, Anti-Anemic Preparations, Anti-Inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplement, Vitamin and Dietary Supplement, Pregnancy, Others)
  • 5.2.3. By End Use (Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies, Contract Manufacturing Organization)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Softgel Capsules Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Softgel Capsules Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Softgel Capsules Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Softgel Capsules Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End Use

7. Europe Softgel Capsules Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Softgel Capsules Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End Use
  • 7.3.2. France Softgel Capsules Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End Use
  • 7.3.3. United Kingdom Softgel Capsules Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End Use
  • 7.3.4. Italy Softgel Capsules Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Softgel Capsules Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End Use

8. Asia Pacific Softgel Capsules Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Softgel Capsules Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Softgel Capsules Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Softgel Capsules Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Softgel Capsules Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Softgel Capsules Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End Use

9. Middle East & Africa Softgel Capsules Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Softgel Capsules Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End Use
  • 9.3.2. UAE Softgel Capsules Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End Use
  • 9.3.3. South Africa Softgel Capsules Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End Use

10. South America Softgel Capsules Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Softgel Capsules Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End Use
  • 10.3.2. Colombia Softgel Capsules Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End Use
  • 10.3.3. Argentina Softgel Capsules Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Softgel Capsules Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Fuji Capsule Co Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sirio Pharma Co Ltd
• 15.3. Captek Softgel International Inc
• 15.4. Thermo Fisher Scientific Inc
• 15.5. EyePoint Pharmaceuticals Inc
• 15.6. Catalent Inc
• 15.7. EuroCaps Ltd
• 15.8. Aenova Group GmbH
• 15.9. Lonza Group AG
• 15.10. Soft Gel Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer